Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17903088 | 0.99 | ALOX5 (0.39) | ALOX5HDAC8MAOBKDM4EALDH1A1 | |
| SCHEMBL16996071 | 0.94 | ALOX5 (0.38) | ALOX5HDAC8MAOBKDM4EALDH1A1 | |
| SCHEMBL16996063 | 0.93 | ALOX5 (0.39) | ALOX5HDAC8MAOBKDM4EALDH1A1 | |
| SCHEMBL17804920 | 0.91 | ALOX5 (0.43) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL17126404 | 0.91 | ALOX5 (0.43) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL17804841 | 0.91 | ALOX5 (0.43) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL29789474 | 0.91 | ALOX5 (0.43) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL17804838 | 0.91 | ALOX5 (0.45) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL17804876 | 0.91 | ALOX5 (0.45) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 | |
| SCHEMBL17816698 | 0.90 | ALOX5 (0.43) | ALOX5KDM4ELMNAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756275-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10756275-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment | CHRM1, L1CAM, ESR1 | ALOX5 1925/4885HDAC8 4082/4885MAOB 2542/4885 |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | CHRM1, L1CAM, ESR1 | ALOX5 1925/4885HDAC8 4082/4885MAOB 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.